Fenofibrate Tablets
Abbott Laboratories
Site Map | Contact Us

NCEP Expert Panel Third Report (1)

Lipid risk factors and predictors for CHD (1)

NCEP defines the lipid triad as a common form of dyslipidemia, characterized by three lipid abnormalities: elevated TG, small LDL particles, and reduced HDL-C.


The independent effect of raising HDL-C or lowering TG on the risk of cardiovascular morbidity and mortality has not been determined (2).

Adherence is critical to successful therapy (1)

  • Most patients do not successfully self-administer medical treatments as prescribed.
  • Poor adherence with lipid-modifying therapy threatens the success of any set of recommendations.
  • Lack of adherence can cause patients to miss the benefits of their treatment.
  • Simplifying the medication regimen is one of many key components to improving adherence.

References

  1. National Heart, Lung, and Blood Institute. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, Md: National Institutes of Health; 2002. NIH Publication 02-5215.
  2. TriCor tablets package insert, Abbott Laboratories.
06H-030-Q590-5